FDA warned SANA Group that website claims make Sleep Sana Sleep Drops and Sleep Shots unapproved new drugs and misbranded.
What happened
FDA reviewed www.sleepsana.com in December 2020 and found that SANA Group takes orders there for Sleep Sana “Sleep Drops” and “Sleep Shots.” FDA cited website claims about ingredients such as GABA, L-tryptophan, valerian, and melatonin as evidence that the products are intended to treat diseases.
What FDA found
Website claims show the products are intended to cure, mitigate, treat, or prevent disease, making them drugs.
section 201(g)(1)(B) of the Act [21 U.S.C. § 321(g)(1)(B)]The products are not generally recognized as safe and effective for the claimed uses, so they are new drugs that cannot be sold without FDA approval.
section 201(p) [21 U.S.C. § 321(p)]; sections 301(d) and 505(a) [21 U.S.C. §§ 331(d), 355(a)]The products lack adequate directions for use because the claimed diseases cannot be safely self-diagnosed or self-treated without a licensed practitioner.
section 502(f)(1) [21 U.S.C. § 352(f)(1)]; 21 C.F.R. § 201.5Introducing the misbranded products into interstate commerce violates the Act.
section 301(a) [21 U.S.C. § 331(a)]
What FDA wants
FDA asks the company to notify it in writing within 15 working days of receipt of the letter about specific steps taken to correct the violations and prevent recurrence, or to explain why it believes the products are not in violation.
Who should pay attention
- sleep supplement and beverage brands
- online sellers making disease-treatment claims
- marketers of GABA, L-tryptophan, valerian, or melatonin products
This is a summary. Read the original letter on fda.gov.